Breast Cancer Patient Pauses Therapy, Welcomes Baby Boy
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Jenilee Crowley was diagnosed with stage one breast cancer in 2022 at age 38, shortly after her wedding, after finding a lump in her breast that upended her plans to start a family.
- Crowley underwent a double mastectomy to remove the cancer and then began hormone therapy aimed at preventing recurrence.
- Under medical guidance from her team at Dana-Farber Cancer Institute, Crowley paused hormone therapy so she and her husband could freeze embryos and attempt pregnancy.
- Crowley's son, Archer, is now four months old, conceived using embryos created during the therapy pause.
- Cancer treatments such as chemotherapy and radiation carry side effects — including hormone changes and potential organ damage — that can threaten a patient's fertility, making preservation options a growing concern for younger patients.
Why it matters: Cancer treatments like chemotherapy and radiation carry fertility-threatening side effects, and the option to temporarily pause hormone therapy under coordinated oncology care gives young patients a path to biological parenthood previous generations didn't have. For a growing population of young cancer patients, this kind of oncology-reproductive coordination is shifting from a luxury add-on to an expected component of treatment planning.
Ask SkimNews
